Brief: Xintela Gets Tissue Establishment License
19/03/2021 12:31
March 19 (Reuters) - Xintela AB XINT.ST :
* XINTELA GETS TISSUE ESTABLISHMENT LICENSE
* HAS RECEIVED A TISSUE ESTABLISHMENT LICENSE FROM SWEDISH
MEDICAL
PRODUCTS AGENCY FOR HANDLING HUMAN TISSUES AND CELLS FOR
MANUFACTURING MEDICINAL PRODUCTS
Source text for Eikon: ID:nBQN8mz7Bb
Further company coverage: XINT.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))
Recent news on Xintela AB
See all newsBrief: Xintela To Raise SEK 30 Mln Via Convertible Loan From Flerie Invest
Advisory: Alerts on Xintela's phase I/IIa XSTEM results withdrawn
Brief: Xintela Q1 2026 Loss Before Tax SEK 11.8 Mln
Brief: Xintela Study Finds XSTEM Treatment Safe, Well Tolerated
Brief: Xintela Gets U.S. Patent For Xstem Treatment Of Difficult-To-Heal Wounds, Skin Defects